Warning! GuruFocus detected
1 Severe warning sign
with BBLG.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Bone Biologics Corp
NAICS : 325412
SIC : 3842
ISIN : US0980702049
Description
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.9 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 59.7 | |||||
| 3-Year EPS without NRI Growth Rate | 63.5 | |||||
| 3-Year FCF Growth Rate | 65.2 | |||||
| 3-Year Book Growth Rate | -80.2 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 21.86 | |||||
| 9-Day RSI | 28.69 | |||||
| 14-Day RSI | 32.89 | |||||
| 3-1 Month Momentum % | -28.6 | |||||
| 6-1 Month Momentum % | -53.92 | |||||
| 12-1 Month Momentum % | -55.73 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 10.21 | |||||
| Quick Ratio | 10.21 | |||||
| Cash Ratio | 8.8 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -309.6 | |||||
| Shareholder Yield % | -111.08 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -122.66 | |||||
| ROA % | -109.99 | |||||
| ROIC % | -1300.06 | |||||
| ROC (Joel Greenblatt) % | -1564.41 | |||||
| ROCE % | -125.85 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.61 | |||||
| Price-to-Tangible-Book | 0.61 | |||||
| EV-to-EBIT | 0.23 | |||||
| EV-to-EBITDA | 0.23 | |||||
| EV-to-FCF | 0.24 | |||||
| Price-to-Net-Current-Asset-Value | 0.61 | |||||
| Price-to-Net-Cash | 0.72 | |||||
| Earnings Yield (Greenblatt) % | 434.78 | |||||
| FCF Yield % | -175.12 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BBLG
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bone Biologics Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -4.865 | ||
| Beta | 0.1 | ||
| 3-Year Sharpe Ratio | -1.51 | ||
| 3-Year Sortino Ratio | -1.7 | ||
| Volatility % | 123.73 | ||
| 14-Day RSI | 32.89 | ||
| 14-Day ATR ($) | 0.06793 | ||
| 20-Day SMA ($) | 0.831765 | ||
| 12-1 Month Momentum % | -55.73 | ||
| 52-Week Range ($) | 0.7 - 4.25 | ||
| Shares Outstanding (Mil) | 3.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bone Biologics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bone Biologics Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bone Biologics Corp Frequently Asked Questions
What is Bone Biologics Corp(BBLG)'s stock price today?
The current price of BBLG is $0.72. The 52 week high of BBLG is $4.25 and 52 week low is $0.70.
When is next earnings date of Bone Biologics Corp(BBLG)?
The next earnings date of Bone Biologics Corp(BBLG) is 2025-05-14 Est..
Does Bone Biologics Corp(BBLG) pay dividends? If so, how much?
Bone Biologics Corp(BBLG) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers